The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 21

More JCP Articles

JCP
Bridge Symptoms Between Borderline Personality and PTSD
Original Research

September 9, 2024

Self-aggression, feelings of emptiness, dissociation, and feelings of detachment were found to be bridge symptoms between borderline personality disorder and PTSD. Targeting these might allow better prevention and management…
, , , et al
JCP
Collaborative vs Specialty Care for Depression or Anxiety
Original Research

September 4, 2024

Model effects at 6 months revealed that patients assigned to collaborative care showed significantly greater improvement than those assigned to specialty psychiatry.
, , , et al
JCP
Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine
Original Research

September 4, 2024

This study suggests that cognitive function does not moderate depression outcomes in vortioxetine, with results comparable to other antidepressants.
, , , et al
JCP
Perinatal Timing of OCD Onset
Original Research

August 28, 2024

Findings show that OCD is most likely to begin in the early postpartum, with a rapid transition from symptoms to disorder. People with pre-existing OCD are vulnerable to symptom…
, ,
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
, , , et al
JCP
Reproductive Pharmacovigilance and Best Practices
Commentary

August 26, 2024

Dr Freeman discusses a recent study by Pacilio et al that characterized real world practices around ketamine treatment and pregnancy testing, consent processes, and contraception use. She emphasizes the…
JCP
Safe Ketamine Use and Pregnancy: A Nationwide Survey
Original Research

August 26, 2024

Risks of fetal ketamine exposure are often overlooked, indicating a need for awareness about reproductive concerns when prescribing ketamine for psychiatric disorders.
, , , et al
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.
JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Narrative Review

August 19, 2024

While the pathophysiology of schizophrenia is complex, treatments with novel pharmacological actions that target these systems are of interest as adjunctive treatment for schizophrenia.
, , , et al
JCP
Prevalence and Course of Unwanted, Intrusive Thoughts of Infant-Related Harm
Original Research

August 14, 2024

Although intrusive thoughts of accidental and intentional infant harm are a common and normative postpartum experience, they cause distress for many new mothers. Clinically significant symptoms that remain by…
, , , et al
JCP
Differentiation Across Bipolar Disorder and MDD by Whole-Night Polysomnographic Findings
Original Research

August 14, 2024

PSG-measured sleep abnormalities, such as reduced REM latency, may be a diagnostic differentiating factor between MDD and bipolar disorder.
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe